Navigation Links
PharmaNet Collaborates With the Cancer Immunotherapy Trials Network

PRINCETON, N.J., June 1, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that it is collaborating with the Cancer Immunotherapy Trials Network (CITN), a premier network of clinical investigators, institutions and thought leaders in the area of cancer immunotherapy and vaccines, in order to help identify trials with immunotherapy agents prioritized by the CITN as having high potential for cancer therapy.

"We are thrilled to collaborate with the Cancer Immunotherapy Trials Network multi-investigator team," commented Anthony Maida, PhD, MA, MBA, Vice President, Clinical Research and General Manager, Oncology. "The association allows us to identify oncology centers of excellence and thought leaders to collaborate on the development of cutting-edge therapeutics."

PharmaNet has been conducting clinical studies for innovative oncology products since 1996 and has an experienced team, including on-staff oncologists, dedicated to the development of cancer treatments.  The Company has extensive experience in the development of cytotoxic chemotherapies, monoclonal antibodies, pathway inhibitors and therapeutic vaccines in most solid tumor types. Two hundred local, regional and global oncology clinical trials have been awarded to PharmaNet in the past five years, including eleven registration programs, seven which resulted in NDA/MAA approvals.

PharmaNet's focus on the development of immunotherapies and cancer vaccines is based on a core team of immunotherapy experts and partnerships to support this initiative.

"Clinical development of immunotherapies and cancer vaccines requires a special understanding of the mechanism of action and a different approach than traditional cancer therapies," Dr. Maida added.  "We are working with clients to address the unique methodologies needed to evaluate efficacy and safety of this class of innovative therapeutics."

About PharmaNetPharmaNet Development Group, Inc., a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit

About Cancer Immunotherapy Trials Network (CITN)The CITN is a multi-investigator team formed to bring new immunotherapy agents to the clinic, with an emphasis on clinical trials of "high priority" agents that were identified at the 2007 National Cancer Institute (NCI) immunotherapy agent workshop and on clinical trials using combination products. In 2010, the CITN was funded by the National Institute for Health through a $14 million grant to the Fred Hutchinson Cancer Research Center where Dr. Martin 'Mac' Cheever is a principle investigator. For more information, please visit

Anne-Marie HessPhone:

(609) 951-6842E-mail:

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009
2. Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
3. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
4. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
5. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
6. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
7. PharmaNet Development Group Announces Observational Research Survey
8. PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
9. PharmaNets Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics
10. Catherine Derasp Joins PharmaNet as Vice President, Clinical Operations
11. PharmaNet and Anapharm Europe Formally End Joint Venture
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  ARKRAY ... products, continues to provide evidence demonstrating the accuracy of ... World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease ... that both the Company,s GLUCOCARD ® 01 meter ... high accuracy requirements. The ability to accurately measure glucose ...
(Date:11/25/2015)... 25, 2015  Trovagene, Inc. (NASDAQ: TROV ), ... Chief Executive Officer Antonius Schuh, Ph.D., is scheduled to ... Annual Piper Jaffray Healthcare Conference. th ... Palace Hotel in New York ... Mr. Schuh will be available for one-on-one meetings during ...
(Date:11/25/2015)... Ohio , Nov. 25, 2015 ... handle hazardous drug preparations (e.g. pharmacists, pharmacy technicians, ... and veterinary technicians). The chapter also covers all ... drugs (e.g., pharmacies, hospitals, other healthcare institutions, patient ... --> --> ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve the ... bather’s style and personality. From basic styles for the purist looking for simplicity ...
(Date:11/25/2015)... ... 2015 , ... Ministers, senior government and UN agencies, representatives ... of Excellence, and public R&D institutions, civil societies and other partners gathered today ... African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day ...
(Date:11/25/2015)... TX (PRWEB) , ... November 25, 2015 , ... For ... the companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two ... services to aid in MAP International’s cause. , MAP International was founded in 1954 ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview ... the country to celebrate their sobriety and show through pictures what a positive ... after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
Breaking Medicine News(10 mins):